Bellevue Life Sciences Acquisition (BLAC) Competitors $1.13 -0.04 (-3.42%) As of 05/19/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BLAC vs. PETV, VVOS, IRIX, CLGN, NRXS, XAIR, NXL, LFWD, BTCY, and ICUShould you be buying Bellevue Life Sciences Acquisition stock or one of its competitors? The main competitors of Bellevue Life Sciences Acquisition include PetVivo (PETV), Vivos Therapeutics (VVOS), IRIDEX (IRIX), CollPlant Biotechnologies (CLGN), NeurAxis (NRXS), Beyond Air (XAIR), Nexalin Technology (NXL), ReWalk Robotics (LFWD), Biotricity (BTCY), and SeaStar Medical (ICU). These companies are all part of the "medical equipment" industry. Bellevue Life Sciences Acquisition vs. PetVivo Vivos Therapeutics IRIDEX CollPlant Biotechnologies NeurAxis Beyond Air Nexalin Technology ReWalk Robotics Biotricity SeaStar Medical PetVivo (NASDAQ:PETV) and Bellevue Life Sciences Acquisition (NASDAQ:BLAC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, community ranking, profitability, earnings and risk. Is PETV or BLAC more profitable? Bellevue Life Sciences Acquisition has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Bellevue Life Sciences Acquisition's return on equity of 0.00% beat PetVivo's return on equity.Company Net Margins Return on Equity Return on Assets PetVivo-902.82% -4,813.07% -281.78% Bellevue Life Sciences Acquisition N/A N/A N/A Which has more volatility & risk, PETV or BLAC? PetVivo has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Comparatively, Bellevue Life Sciences Acquisition has a beta of -0.08, meaning that its stock price is 108% less volatile than the S&P 500. Do institutionals & insiders have more ownership in PETV or BLAC? 24.5% of PetVivo shares are owned by institutional investors. Comparatively, 55.3% of Bellevue Life Sciences Acquisition shares are owned by institutional investors. 10.8% of PetVivo shares are owned by company insiders. Comparatively, 33.7% of Bellevue Life Sciences Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to PETV or BLAC? In the previous week, PetVivo's average media sentiment score of 0.00 equaled Bellevue Life Sciences Acquisition'saverage media sentiment score. Company Overall Sentiment PetVivo Neutral Bellevue Life Sciences Acquisition Neutral Which has preferable valuation & earnings, PETV or BLAC? Bellevue Life Sciences Acquisition has lower revenue, but higher earnings than PetVivo. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPetVivo$1.05M17.05-$10.95M-$0.45-1.64Bellevue Life Sciences AcquisitionN/AN/AN/AN/AN/A Does the MarketBeat Community prefer PETV or BLAC? PetVivo and Bellevue Life Sciences Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformPetVivoN/AN/ABellevue Life Sciences AcquisitionN/AN/A SummaryBellevue Life Sciences Acquisition beats PetVivo on 5 of the 7 factors compared between the two stocks. Get Bellevue Life Sciences Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BLAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLAC vs. The Competition Export to ExcelMetricBellevue Life Sciences AcquisitionHolding Offices IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$4.57M$477.17M$2.05B$8.39BDividend YieldN/A7.55%2.63%4.10%P/E RatioN/A2.5322.6819.71Price / SalesN/A68.5159.36117.28Price / CashN/A69.0151.7234.62Price / BookN/A6.842.094.50Net IncomeN/A$35.22M-$292.00M$248.18M7 Day Performance-6.61%0.45%0.13%0.23%1 Month Performance-15.04%3.32%10.23%12.39%1 Year Performance-89.47%24.62%11.36%7.07% Bellevue Life Sciences Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLACBellevue Life Sciences AcquisitionN/A$1.13-3.4%N/A-89.5%$4.57MN/A0.00N/AGap UpHigh Trading VolumePETVPetVivoN/A$0.79+10.4%N/A+9.8%$19.26M$1.05M-1.7620VVOSVivos Therapeutics1.4133 of 5 stars$3.14flat$6.10+94.3%-5.5%$18.50M$15.03M-0.55160Earnings ReportIRIXIRIDEX0.8061 of 5 stars$1.10-4.3%$2.00+81.8%-62.1%$18.47M$48.67M-1.64120News CoverageAnalyst ForecastCLGNCollPlant Biotechnologies2.5439 of 5 stars$1.55-5.5%$12.50+706.5%-67.5%$17.76M$515,000.00-1.0170Upcoming EarningsNRXSNeurAxisN/A$2.30-0.9%N/A+4.9%$16.60M$2.69M-1.2519News CoverageGap DownHigh Trading VolumeXAIRBeyond Air3.968 of 5 stars$0.19-3.2%$1.50+694.9%-85.7%$16.30M$3.02M-0.1870Positive NewsGap DownNXLNexalin Technology2.7856 of 5 stars$1.19-4.8%$5.00+320.2%+1.7%$15.86M$168,721.00-1.863LFWDReWalk Robotics2.8179 of 5 stars$1.42+4.4%$9.00+533.8%-76.5%$15.10M$25.66M-0.5760Earnings ReportBTCYBiotricityN/A$0.52+0.6%N/A-52.7%$12.88M$12.06M-0.4840Gap UpICUSeaStar Medical0.9756 of 5 stars$1.27flatN/A-87.2%$12.45M$135,000.00-0.112 Related Companies and Tools Related Companies PETV Competitors VVOS Competitors IRIX Competitors CLGN Competitors NRXS Competitors XAIR Competitors NXL Competitors LFWD Competitors BTCY Competitors ICU Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLAC) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BLAC Stock Free BLAC Stock Alerts